Status:
COMPLETED
Investigation of Cisplatin-Related Kidney Toxicity
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
American Society of Clinical Oncology
National Institutes of Health (NIH)
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to identify novel biomarkers of kidney injury in patients receiving cisplatin. This study will also collect DNA for future analysis.
Detailed Description
This study will look for novel biomarkers of kidney injury in patients receiving cisplatin in patients currently receiving cisplatin. DNA will be collected both prospectively and retrospectively (fro...
Eligibility Criteria
Inclusion
- Prospective Analysis Group
- Patients about to receive intravenous cisplatin for the first time as part of cancer chemotherapy.
- Aged 18 years and older.
- Ability to understand and willingness to sign a written consent document.
- Patients may be receiving cisplatin in combination with other chemotherapeutic agents.
- Patients may be receiving cisplatin in the context of another clinical trial.
Exclusion
- Prior receipt of cisplatin.
- Patients on dialysis or other renal replacement therapy prior to starting cisplatin.
- Uncontrolled hypo- or hyperthyroidism (patients on chronic stable doses of thyroid replacement medication are eligible).
- Retrospective Analysis Group
- Inclusion Criteria:
- Patients that have previously received intravenous cisplatin as part of cancer chemotherapy.
- Aged 18 years and older.
- Ability to understand and willingness to sign a written consent document.
- Patients that received cisplatin in combination with other chemotherapeutic agents are eligible.
- Patients that received cisplatin in the context of a clinical trial are eligible.
Key Trial Info
Start Date :
September 22 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT00984035
Start Date
September 22 2009
End Date
March 1 2018
Last Update
September 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637